Jaguar Health, Inc.
JAGX
$2.58
$0.010.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.83% | 52.57% | 10.49% | 1.68% | 19.22% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.83% | 52.57% | 10.49% | 1.68% | 19.22% |
| Cost of Revenue | 19.77% | -18.92% | 5.25% | -13.03% | 24.64% |
| Gross Profit | -11.56% | 83.01% | 11.66% | 4.99% | 18.07% |
| SG&A Expenses | 26.89% | 23.22% | 15.60% | -2.86% | -13.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.12% | 22.98% | -10.60% | -7.98% | -10.59% |
| Operating Income | -14.68% | -13.51% | 17.36% | 11.17% | 16.56% |
| Income Before Tax | -13.11% | -9.94% | -26.78% | 21.67% | 24.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.11% | -9.94% | -26.78% | 21.67% | 24.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -7.04% | 125.90% | 32.54% | -3.55% | -27.18% |
| Net Income | -13.42% | -8.18% | -26.69% | 21.88% | 24.39% |
| EBIT | -14.68% | -13.51% | 17.36% | 11.17% | 16.56% |
| EBITDA | -15.92% | -14.89% | 18.05% | 11.17% | 17.42% |
| EPS Basic | 80.83% | 92.60% | 95.33% | 90.23% | -- |
| Normalized Basic EPS | 83.10% | 92.36% | 96.84% | 90.24% | -- |
| EPS Diluted | 80.83% | 92.60% | 95.33% | 90.23% | -- |
| Normalized Diluted EPS | 83.10% | 92.36% | 96.84% | 90.24% | -- |
| Average Basic Shares Outstanding | 491.69% | 1,361.04% | 2,615.94% | 696.61% | -- |
| Average Diluted Shares Outstanding | 491.69% | 1,361.04% | 2,615.94% | 696.61% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |